FIELD: medicine.
SUBSTANCE: invention relaters to medicine, namely to oncology and surgery, and is intended for predicting outcome of treatment of patient with urinary bladder cancer. Determined are depth of tumour invasion into urinary bladder (a1), histologic type of urinary bladder cancer (a2), histopathologic gradation of urinary bladder cancer (a3), tumour sensitivity to PCT (a4), volume of performed treatment (a5), diseases of genitourinary system, leading to infravesical obstruction (a6), tumour localisation (a7). After that, prediction of distant results of urinary bladder cancer treatment is determined by formula: y = a0+a1x+a2x+a3x+a4x+a5x+a6x+a7x, where a0 (free member) = -1.35, a1 = 0.26, a2 = 0.13, a3 =0.22, a4 = 0.41, a5 = 0.37, a6 = 0.15, a7 = 0.06, x is numerical value, taken for certain patient and selected from table 1 given in description, depending on type and degree of parameters of prognostic factors (a1 - a7). Prediction is considered good if y lies within the interval 0-2.5, prediction is considered to ne satisfactory if the number is within the interval 2.6-3.5, prediction is considered to be doubtful if y value is within the interval 3.6-4.5, prediction is considered unsatisfactory if y value is larger than 4.6.
EFFECT: method makes it possible to determine prediction prospectively, optimise treatment tactics and form complex of measures of tertiary prevention.
2 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATMENT IN CASE OF URINARY BLADDER CANCER | 2010 |
|
RU2457846C2 |
METHOD FOR ASSESSING SURGICAL RADICALITY IN SKIN CANCER | 2011 |
|
RU2465587C1 |
METHOD OF LOCAL PROLONGED CHEMICAL-THERAPEUTIC TREATMENT OF LOCALLY SPREAD UNRESECTABLE GLANDULAR CANCER OF PELVIS MINOR ORGANS | 2010 |
|
RU2437660C1 |
METHOD FOR BLADDER CANCER COURSE PREDICTION | 2017 |
|
RU2641170C1 |
METHOD OF LYMPHODISSECTION IN VIVO AT CANCER | 2007 |
|
RU2340293C1 |
METHOD OF PREDICTING THE EFFECTIVENESS OF CHEMOTHERAPY IN BLADDER CANCER ACCORDING TO MAGNETIC RESONANCE IMAGING | 2022 |
|
RU2800817C1 |
BIOMATERIAL AND PREPARATION WITH BIOMATERIAL, STIMULATING ANTI-TUMOUR ACTIVITY | 2013 |
|
RU2526160C1 |
METHOD FOR PREDICTING COURSE OF NECROTIZING ENTEROCOLITIS IN NEWBORN INFANTS | 2014 |
|
RU2585418C2 |
METHOD FOR PREDICTING RECURRENCE OF NON-MUSCLE INVASIVE BLADDER CANCER | 2022 |
|
RU2793510C1 |
METHOD OF PREDICTING THE DEVELOPMENT OF RELAPSE IN PATIENTS WITH HUMAN PAPILLOMAVIRUS AND NON-MUSCLE-INVASIVE BLADDER CANCER | 2022 |
|
RU2800265C1 |
Authors
Dates
2012-07-27—Published
2010-07-05—Filed